201 – 210 of 469
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Reducing Unnecessary Biopsy During Prostate Cancer Screening Using a Four-Kallikrein Panel: An Independent Replication.
- Contribution to journal › Article
-
Mark
Empirical Estimates of the Lead Time Distribution for Prostate Cancer Based on Two Independent Representative Cohorts of Men Not Subject to Prostate-Specific Antigen Screening.
(2010) In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology May 4. p.1201-1207
- Contribution to journal › Article
-
Mark
Mass spectrometric strategy for clearcut identification of prostate specific antigen in clinical Samples
(2010) 4th EuPA Scientific Meeting - A Proteomics Odyssey Towards Next Decades In [Publication information missing] p.114-117
- Contribution to journal › Published meeting abstract
-
Mark
Characterization of PSA in clinical samples by mass spectrometry
(2010) 4th EuPA Scientific Meeting - A Proteomics Odyssey Towards Next Decades In [Publication information missing] p.508-510
- Contribution to journal › Published meeting abstract
-
Mark
Characterization of PSA in clinical samples by mass spectrometry
(2010) Swedish Proteomics Society Symposium, 2010
- Contribution to conference › Abstract
-
Mark
Extraction of circulating tumor cells from blood using acoustophoresis
(2010) 14th International Conference on Miniaturized Systems for Chemistry and Life Sciences 2010, MicroTAS 2010 In 14th International Conference on Miniaturized Systems for Chemistry and Life Sciences 2010, MicroTAS 2010 3. p.1592-1594
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Detection of androgen receptor mutations in circulating tumor cells : Highlights of the long road to clinical qualification
- Contribution to journal › Article
-
Mark
The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine
- Contribution to journal › Article
-
Mark
Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer : Case-control study
- Contribution to journal › Article
-
Mark
A panel of kallikrein markers can predict outcome of prostate biopsy following clinical work-up : An independent validation study from the European Randomized Study of Prostate Cancer screening, France
- Contribution to journal › Article
